Medical Oncology

Dr. Mehmet Teomete

Doctor and researcher Acıbadem Ataşehir Hastanesi İstanbul
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Testis Kanseri
  • Yumurtalık (Over) Kanseri
  • Mide Kanseri
  • Pankreas Kanseri
  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Meme Kanseri
  • Kemik Tümörleri
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Akciğer Kanseri
  • Kolon (Kalın Bağırsak) Kanseri

CV

Education and experience

From source

Experience

  • 2010Trabzon Numune Eğitim ve Araştırma Hastanesi / Tıbbi Onkoloji Uzmanıacibadem.com.tr
  • 2009 - 2010Erzurum Bölge Eğitim ve Araştırma Hastanesi / Tıbbi Onkoloji Uzmanıacibadem.com.tr
  • 2005 - 2009Marmara Üniversitesi Tıp Fakültesi / Yan Dal Uzmanlık Eğitimiacibadem.com.tr
  • 2004Acıbadem Sağlık Grubuacibadem.com.tr
  • 2003 - 2005Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / İç Hastalıkları Uzmanıacibadem.com.tr
  • 1998 - 2003Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / İç Hastalıkları Asistanıacibadem.com.tr
  • 1996 - 1998Trabzon Merkez Çağlayan Sağlık Ocağı / Pratisyen Hekimacibadem.com.tr
  • 1994 - 1996Trabzon Düzköy İlçesi Aykut Beldesi Sağlık Ocağı / Pratisyen Hekimacibadem.com.tr

Education

  • 2009Marmara Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2003Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1994Ankara Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Ataşehir Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications32 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:46https://www.acibadem.com.tr/doktor/mehmet-teomete/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

32 publications

  1. Abstract P4-11-03: Prediciting high risk hormone receptor (HR) positive Her-2 negative early breast cancer (BC) by artificial intelligence (AI) algorithms

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p4-11-03 Source: OpenAlex

  2. Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review)

    Oncology Letters, 2024

    DOI 10.3892/ol.2024.14278 PMID 38385117 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study

    Japanese Journal of Clinical Oncology, 2024

    DOI 10.1093/jjco/hyae002 PMID 38271177 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

    Journal of Oncology, 2020

    DOI 10.1155/2020/1360431 PMID 32670370 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. 2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1314 Open-access full textSource: OpenAlex

  6. Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz253.091 Source: OpenAlex

  7. Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e24306 Source: OpenAlex

  8. Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.1.117 PMID 24528011 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.

    Europe PMC (PubMed Central), 2014

    PMID 24995112 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  10. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e16015 Open-access full textSource: OpenAlex

View all 32 publications